Literature DB >> 27085187

DJ-1 linked parkinsonism (PARK7) is associated with Lewy body pathology.

Ricardo Taipa1, Conceição Pereira2, Inês Reis3, Isabel Alonso2, António Bastos-Lima4, Manuel Melo-Pires3, Marina Magalhães4.   

Abstract

Mutations in DJ-1 (encoded by PARK7) are a very rare cause of early-onset recessive Parkinson's disease. We describe a patient with early-onset parkinsonism, starting at the age of 22, with poor response to levodopa and additional features in progression (dystonia, pyramidal signs and dementia), who died when he was 49 years old. The neuropathological study showed severe substantia nigra and locus coeruleus neuronal loss, with diffuse Lewy body pathology (Lewy bodies, aberrant neurites, grain-like structures, spheroids and scattered glial pathology). Genetic analysis revealed a novel c.515T > A; p.L172Q mutation in the PARK7 gene. To evaluate the pathogenicity of this new mutation we explored DJ-1 expression levels in vitro showing a massive reduction in DJ-1 protein levels due to a highly unstable and rapidly degraded L172Q mutant. DJ-1 immunohistochemistry of brain tissue revealed no staining in our case. This is the first neuropathological report of a brain from DJ-1-linked parkinsonism that, although based on a single case study, suggests that DJ-1 mutations are causative of α-synucleinopathy. These results can help in the understanding of Parkinson's disease pathophysiology, promote research studies to increase the knowledge on the pathways involved in the neurodegeneration process, and pave the way for new therapeutic interventions.
© The Author (2016). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  DJ-1; Lewy body; PARK7; pathology; α-synuclein

Mesh:

Substances:

Year:  2016        PMID: 27085187     DOI: 10.1093/brain/aww080

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  34 in total

1.  Peripheral synucleinopathy in a DJ1 patient with Parkinson disease, cataracts, and hearing loss.

Authors:  Derek P Narendra; Risa Isonaka; Diana Nguyen; Alice B Schindler; Angela D Kokkinis; Debra Ehrlich; Tanya M Bardakjian; David S Goldstein; Tsao-Wei Liang; Pedro Gonzalez-Alegre
Journal:  Neurology       Date:  2019-04-26       Impact factor: 9.910

Review 2.  CRISPR System: A High-throughput Toolbox for Research and Treatment of Parkinson's Disease.

Authors:  Fatemeh Safari; Gholamreza Hatam; Abbas Behzad Behbahani; Vahid Rezaei; Mazyar Barekati-Mowahed; Peyman Petramfar; Farzaneh Khademi
Journal:  Cell Mol Neurobiol       Date:  2019-11-26       Impact factor: 5.046

Review 3.  Neuropathology of genetic synucleinopathies with parkinsonism: Review of the literature.

Authors:  Susanne A Schneider; Roy N Alcalay
Journal:  Mov Disord       Date:  2017-11       Impact factor: 10.338

4.  Astrocyte-specific DJ-1 overexpression protects against rotenone-induced neurotoxicity in a rat model of Parkinson's disease.

Authors:  Briana R De Miranda; Emily M Rocha; Qing Bai; Amina El Ayadi; David Hinkle; Edward A Burton; J Timothy Greenamyre
Journal:  Neurobiol Dis       Date:  2018-04-09       Impact factor: 5.996

Review 5.  α-Synuclein and astrocytes: tracing the pathways from homeostasis to neurodegeneration in Lewy body disease.

Authors:  Zachary A Sorrentino; Benoit I Giasson; Paramita Chakrabarty
Journal:  Acta Neuropathol       Date:  2019-02-23       Impact factor: 17.088

Review 6.  Animal models of α-synucleinopathy for Parkinson disease drug development.

Authors:  James B Koprich; Lorraine V Kalia; Jonathan M Brotchie
Journal:  Nat Rev Neurosci       Date:  2017-07-13       Impact factor: 34.870

Review 7.  Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update-I. Hypokinetic-rigid movement disorders.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2019-06-18       Impact factor: 3.575

Review 8.  Exploring the Role of Ubiquitin-Proteasome System in Parkinson's Disease.

Authors:  Tapan Behl; Sachin Kumar; Ziyad M Althafar; Aayush Sehgal; Sukhbir Singh; Neelam Sharma; Vishnu Nayak Badavath; Shivam Yadav; Saurabh Bhatia; Ahmed Al-Harrasi; Yosif Almoshari; Mohannad A Almikhlafi; Simona Bungau
Journal:  Mol Neurobiol       Date:  2022-05-03       Impact factor: 5.590

9.  Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson's disease.

Authors:  Lena F Burbulla; Pingping Song; Joseph R Mazzulli; Enrico Zampese; Yvette C Wong; Sohee Jeon; David P Santos; Judith Blanz; Carolin D Obermaier; Chelsee Strojny; Jeffrey N Savas; Evangelos Kiskinis; Xiaoxi Zhuang; Rejko Krüger; D James Surmeier; Dimitri Krainc
Journal:  Science       Date:  2017-09-07       Impact factor: 47.728

Review 10.  Intersection between Redox Homeostasis and Autophagy: Valuable Insights into Neurodegeneration.

Authors:  Hyungsun Park; Jongyoon Kim; Chihoon Shin; Seongju Lee
Journal:  Antioxidants (Basel)       Date:  2021-04-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.